Nityr Tablet
Product Images NDC 70709-005

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Nityr (NDC 70709-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bottle Label)

NITYR (nitisinone) tablets 10 mg oral tablet label includes the NDC 70709-000-60. Marketed by Cycle Pharmaceuticals Ltd, manufactured by PCI Pharma Services. The label indicates storage between 20°C to 25°C, dispensation in a tight, light-resistant container, prescription only, and a count of 60 tablets.*

FDA Label Image

Principal Display Panel (Bottle Label)

Label for NITYR (nitisinone) tablets 2 mg, an oral human prescription drug. The label states storage conditions, dispensing instructions, and manufacturer details: marketed by Cycle Pharmaceuticals Ltd., UK, and manufactured by PCI Pharma Services, UK. The package contains 60 tablets and includes a barcode and lot/expiration information areas.*

FDA Label Image

Principal Display Panel (10 mg Bottle Label)

NITYR (nitisinone) tablets 5 mg label for oral use. The label indicates the product is dispensed in a tight, light-resistant container and stored at room temperature between 20°C to 25°C (68°F to 77°F). It is marketed by Cycle Pharmaceuticals Ltd, UK, and manufactured by PCI Pharma Services, UK. The package contains 60 tablets and is prescription-only.*

FDA Label Image

Principal Display Panel (10 mg Carton)

NITYR (nitisinone) tablets 10 mg packaging label for oral use, containing 60 tablets. Marketed by Cycle Pharmaceuticals Ltd, UK, and manufactured by PCI Pharma Services, UK. The label includes storage instructions, inactive ingredients, NDC 70709-000-60, and manufacturer contact information.*

FDA Label Image

Principal Display Panel (2 mg Carton)

NITYR (nitisinone) tablets 2 mg label for oral use, marketed by Cycle Pharmaceuticals Ltd. The label states each tablet contains 2 mg nitisinone with inactive ingredients glycerol dibehenate and lactose monohydrate. The package contains 60 tablets and includes storage instructions to keep at 20°C to 25°C with permitted excursions. Manufacturer is PCI Pharma Services, UK. Contact information for Cycle Pharmaceuticals Ltd is provided.*

FDA Label Image

Principal Display Panel (5 mg Carton)

Packaging label for NITYR (nitisinone) tablets 5 mg, oral dosage form, containing 60 tablets per container. Marketed by Cycle Pharmaceuticals Ltd and manufactured by PCI Pharma Services in the UK. Label includes storage instructions, inactive ingredients, contact information, and barcode.*

FDA Label Image

Ifu 1 (Ifu 01)

An instructional diagram of an oral syringe labeled with parts including cap, tip, barrel with mL markings from 1 to 5, and plunger. The image depicts the components of an oral syringe used for liquid medication administration.*

FDA Label Image

Ifu 2 (Ifu 02)

An instructional illustration showing a syringe positioned above a graduated measuring container. The image depicts the action of emptying the syringe contents into the container, which is marked with volume measurements up to 10 ml.*

FDA Label Image

Ifu 3 (Ifu 03)

An instruction-style illustration showing a vertical syringe-like device with measurement markings and a plunger, likely demonstrating a dosing or administration technique associated with the product.*

FDA Label Image

Ifu 4 (Ifu 04)

An instructional diagram illustrating the assembly and use of a syringe with a plunger, showing measurement markings, air space, and a liquid level at approximately 2.6 mL in the syringe barrel placed within a container. This is likely part of preparation or dosing instructions.*

FDA Label Image

Ifu 5 (Ifu 05)

An instructional illustration shows three stages labeled 'BEFORE,' 'DURING,' and 'AFTER,' depicting a liquid measurement process using a syringe and a small container over a 60-minute period. The syringe contents change from clear before to cloudy after, with bubbles forming in the container during the process.*

FDA Label Image

Ifu 6 (Ifu 06)

An instructional illustration showing how to mix or shake a syringe and vial preparation. It depicts a syringe attached to a vial with arrows indicating rotation back and forth over 30 seconds to ensure proper mixing.*

FDA Label Image

Ifu 7 (Ifu 07)

Illustration of a syringe labeled with volume measurements in milliliters (mL), containing small solid pieces at the top. This diagram likely relates to a medication preparation or administration process, showing the contents and volume in the syringe barrel.*

FDA Label Image

Ifu 8 (Ifu 08)

An instructional diagram depicting a syringe with measurement markings on the barrel and a separate small cap or cover shown beside it, illustrating assembly or usage steps associated with the syringe components.*

FDA Label Image

Ifu 9 (Ifu 09)

Illustration showing a side view of a person's face demonstrating the oral administration technique using a syringe (without needle), aimed toward the open mouth. The image is labeled with the letter 'H' below the illustration.*

FDA Label Image

Ifu 10 (Ifu 10)

An instructional diagram of a syringe filled with fluid, marked with volume graduations and a labeled air bubble near the tip. The syringe is shown in a vertical orientation with a plunger.*

FDA Label Image

Ifu 11 (Ifu 11)

Illustration showing a syringe with markings indicating a volume of approximately 2 mL. The syringe is positioned above a small cup or container, with an upward arrow indicating the syringe plunger can be pulled back. This diagram appears instructional but does not reference NITYR or its tablets.*

FDA Label Image

Ifu 12 (Ifu 12)

An instructional diagram showing a syringe with a plunger and measurement markings. The image indicates vertical movement of the plunger, suggesting adjustment or drawing of fluid. No specific drug information is visible in the image.*

FDA Label Image

Ifu 13 (Ifu 13)

An instructional illustration showing a syringe with measurement markings, a plunger at the top, and an attached needle with a protective cap positioned below. An arrow indicates the needle cap is to be removed by pulling downward.*

FDA Label Image

Ifu 14 (Ifu 14)

An instructional illustration depicting a person opening their mouth wide, with an arrow indicating the placement of an oral tablet or medication into the mouth. No product-specific markings or text are visible.*

FDA Label Image

Ifu 15 (Ifu 15)

An instructional diagram of a syringe held upright showing markings and a cap at the top, with an arrow indicating the direction to pull or push. The letter 'N' is shown below the syringe.*

FDA Label Image

Ifu 16 (Ifu 16)

An instructional illustration showing how to place two tablets into a dosing syringe. The syringe is marked with graduated measurements from 1 to 7 milliliters, indicating volume. This type of diagram typically demonstrates tablet preparation or administration steps involving a measuring syringe.*

FDA Label Image

Ifu 17 (Ifu 17)

An instructional black-and-white line drawing of a syringe with measurement markings visible on the barrel, showing detail of the plunger and tip. The illustration is labeled with the letter 'B' beneath the syringe image.*

FDA Label Image

Ifu 18 (Ifu 18)

An instructional diagram showing a syringe labeled with milliliter (mL) graduations up to 5 mL, with air indicated above the plunger, and the syringe tip inserted into a container labeled 'C'. The illustration appears to demonstrate liquid measurement or preparation technique.*

FDA Label Image

Ifu 19 (Ifu 19)

An instructional illustration showing three panels labeled BEFORE, DURING, and AFTER. The BEFORE and AFTER panels display a syringe with liquid inside, and the DURING panel shows a vial with bubbles rising, indicating a process occurring over 60 minutes. This likely demonstrates a preparation or dissolution step involving the syringe and vial.*

FDA Label Image

Ifu 20 (Ifu 20)

An instructional diagram showing the use of a syringe and vial, illustrating a back-and-forth motion for 30 seconds, likely demonstrating mixing or drawing up medication.*

FDA Label Image

Ifu 21 (Ifu 21)

An illustration showing a syringe with an unknown medication inside, labeled with the letter "F" below the syringe. The syringe is filled with liquid and is marked with measurement lines. The part of the syringe above the plunger is labeled "small pieces." The image appears to be instructional or related to medication preparation or administration.*

FDA Label Image

Ifu 22 (Ifu 22)

An illustration showing a syringe with a plunger and measurement markings on the barrel, alongside a small detached cap or lid. The image appears to depict part of an injection or preparation process, without identifying any specific medication or dosage.*

FDA Label Image

Ifu 23 (Ifu 23)

An instructional diagram showing a person administering an oral medication using a syringe. The syringe is positioned at the side of the open mouth, aimed toward the back of the throat, illustrating the proper method for oral dosing.*

FDA Label Image

Ifu 24 (Ifu 24)

An instructional diagram showing a syringe partially filled with liquid and an arrow indicating the presence of air near the bottom of the syringe barrel. The diagram is labeled with measurement gradations on the syringe and an arrow pointing to the air inside.*

FDA Label Image

Ifu 25 (Ifu 25)

An instructional diagram showing a syringe partially filled with liquid, with a measurement marking at approximately 2 mL. The syringe is surrounded by a conical holder, and an arrow points upward from the syringe plunger, indicating movement or aspiration direction.*

FDA Label Image

Ifu 26 (Ifu 26)

An instructional illustration showing a syringe with a plunger and measurement markings. The image highlights a vertical movement indicated by a double-headed arrow next to the syringe, suggesting plunger adjustment or fluid measurement. No specific drug information is visible in the image.*

FDA Label Image

Ifu 27 (Ifu 27)

An instructional illustration showing a syringe with measurement markings and a detachable cap beside it. The image appears to demonstrate the removal or placement of the syringe cap, indicated by a curved arrow. The syringe is partially filled, and the illustration is black and white on a plain background.*

FDA Label Image

Ifu 28 (Ifu 28)

An instructional illustration showing a side profile of a person administering an oral dose using a syringe-like device aimed towards the mouth. The diagram emphasizes the oral route of administration, likely related to the NITYR tablet product.*

FDA Label Image

Ifu 29 (Ifu 29)

An instructional illustration showing a close-up of a syringe with measurement markings and a small funnel or cone-shaped attachment on top, indicating a step in liquid handling or dosing preparation.*

FDA Label Image

Ifu 39 (Ifu 39)

An illustration shows a metal spoon containing a single tablet placed on it. The tablet appears oval-shaped and is positioned centrally in the bowl of the spoon. The spoon is labeled with the letter 'A' underneath it.*

FDA Label Image

Ifu 40 (Ifu 40)

An instructional diagram showing two stages labeled B and C. Image B illustrates a spoon with a label indicating to press and rotate. Image C shows the spoon containing fine powder, demonstrating the powder's texture or presentation.*

FDA Label Image

Ifu 41 (Ifu 41)

An instructional illustration showing a spoon being stirred inside a bowl. The motion is indicated by a dashed curved arrow, suggesting the spoon should be rotated clockwise. The letter 'D' is labeled below the bowl.*

FDA Label Image

Ifu 42 (Ifu 42)

An illustration showing a medicine measuring cup containing small beads or granules with a spoon positioned inside it, labeled with the letter "E" underneath. The image appears to demonstrate a step related to medication preparation or measurement.*

FDA Label Image

Ifu 43 (Ifu 43)

An instructional illustration showing a human mouth open as a spoon containing small granules or powder is being administered orally. The image likely demonstrates how to take a medication in granule or powder form from a spoon into the mouth.*

FDA Label Image

Ifu 44 (Ifu 44)

An illustration showing a spoon being used to scoop powder from a bowl, with an arrow indicating the direction of the powder movement from the spoon back to the bowl.*

FDA Label Image

Ifu 45 (Ifu 45)

An instructional illustration showing a spoon being rotated inside a small glass container labeled with an H. The image likely demonstrates how to mix or measure contents using the spoon in the container.*

FDA Label Image

Ifu 46 (Ifu 46)

Illustration showing a person opening their mouth to receive medication from a spoon, indicating oral administration of the drug.*

FDA Label Image

Figure 1 Structural Formula (Structure)

Chemical structure of nitisinone showing its molecular framework with ketone, nitro, and trifluoromethyl functional groups attached to a cyclohexane and aromatic ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.